The Live Attenuated Vaccines Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Live Attenuated Vaccines Market?
The market for live attenuated vaccines has seen robust expansion in the past couple of years and is projected to further increase from $23.58 billion in 2024 to $25.95 billion in 2025. This suggests a compound annual growth rate (CAGR) of 10.1% in this market.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Live Attenuated Vaccines Industry?
The Live Attenuated Vaccines Global Market size is predicted to grow to $37.56 billion in 2029, with a compound annual growth rate (CAGR) of 9.7%.
Download Your Free Sample of the 2025 Live Attenuated Vaccines Market Report and Uncover Key Trends Now!
Global Market Segmentation: Identifying Major Live Attenuated Vaccines Industry Segments
The live attenuated vaccines market covered in this report is segmented –
1) By Vaccine Type: Monovalent, Multivalent
2) By Route Of Administration: Intramuscular, Subcutaneous, Oral Attenuated, Intranasal Attenuated
3) By Indication: Influenza, Measles, Mumps and Rubella (MMR), Polio, Chickenpox, Shingles, Rotavirus, Other Indications
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
5) By End-User: Hospitals, Clinics, Diagnostic Centers, Research Institute, Other End-Users
What are the Key Growth Drivers Fueling the Live Attenuated Vaccines Market?
The key drivers in the live attenuated vaccines marketare:
• Rising focus on preventive healthcare
• Increasing vaccine adoption in low- and middle-income countries
• Growing importance of outbreak preparedness
• Expansion of government-funded immunization initiatives
Pre-order the 2025 Live Attenuated Vaccines Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Live Attenuated Vaccines Market?
The key trends in the live attenuated vaccines market are:
• There are advancements being made in vaccine delivery systems within the market.
• Innovations are emerging within the field of genetic attenuation techniques in live attenuated vaccines.
• There is an increasing trend of investing more in research and development.
• Thermostable formulations are being developed which is shaping the future of the industry.
Who Are the Top Competitors & Leading Players in the Live Attenuated Vaccines Market?
Major companies in the live attenuated vaccines market are:
• Merck & Co. Inc.
• Sanofi SA
• AstraZeneca plc
• Abbott Laboratories
• GlaxoSmithKline plc
• Takeda Pharmaceutical Company Limited
• Boehringer Ingelheim International GmbH
• CSL Limited
• GC Biopharma
• Serum Institute of India Pvt. Ltd.
• Bavarian Nordic
• Valneva SE
• Southern Research
• BioFarma
• Bharat Biotech International Limited
• Meissa Vaccines Inc.
• BioDiem Ltd.
• Bio-Med Limited
• Naobios
• Lakshmi Pharmaceuticals
Regional Dominance: Which Area Leads the Global Live Attenuated Vaccines Market?
North America was the largest region in the live attenuated vaccines market in 2024
